Wisconsin Spine and Pain SC wispineandpain.com 920-204-6758 Locations in Waukesha, West Bend, Sheboygan and Green Bay. Defendant / Appellee: Bond Pharmacy, Incorporated, doing business as Advanced Infusion Care, doing business as Advanced Infusion Solutions, doing business as AIS Healthcare. Plaintiff requests summons issued. The .gov means its official.Federal government websites often end in .gov or .mil. Fax: 601-988-1701. United States District Court, S.D. You can reach out to the office of Advanced Infusion Solutions via phone at (877) 443-4006 . Release of Transcript Restriction set for 10/4/2021. Cause No. [21-30534] (Imad Sayed Matini ) [Entered: 09/13/2021 03:45 PM], APPEARANCE FORM received from Mr. Paul Anthony Werner, III for Bond Pharmacy, Incorporated for the court's review. (Attachments: #1 Exhibit Exhibit 1) (Knapp, Scott) (Entered: 04/28/2021), Docket(#20) NOTICE OF HEARING BY VIDEO CONFERENCE on #18 MOTION to Dismiss Plaintiff's Amended Complaint. After that date, the transcript is publicly available. A more recent docket listing Cases involving insurance agreements (subrogations, indemnifications, etc. BCBS and AHS, on the other hand, allege the Agreement permitted AIS to bill a per diem rate under the S9328 code "when it performed intrathecal pain pump fill/refills or other infusions in the [m]ember's home or equivalent setting and provided ongoing services, such as medical supervision, care coordination, nursing, patient or caregiver training, and patient support." Id. But they disagree as to whether AIS breached it. Our reports cover every category imaginable! 2002). Id. Dallas, Texas Type Privately Held Founded 1998 Specialties Home Infusion Medication Compounding, Specialty Pharmacy Services, Implanted Pump Medication Compounding, Pharmaceutical Compounding,. 47. Filed: April 5, 2017 Retail pharmacy services; mail order pharmacy services; retail specialty pharmacy services Owned by: Advanced Infusion Solutions Acquisition, LLC Serial Number: 87399568. Lead Counsel? [21-30534] (Paul Anthony Werner III) [Entered: 09/13/2021 03:26 PM], APPEARANCE FORM for the court's review. ADVANCED HEALTH SYSTEMS, INC. and BLUE CROSS & BLUE SHIELD OF MISSISSIPPI, A MUTUAL INSURANCE COMPANY, Defendants. 14. Electronic ROA deadline satisfied. We engage with your physician to offer the highest standard of care. Ct. App. Advanced Infusion Solutions is a medicare enrolled Durable Medical Equipment & Medical Supplies Supplier in Dallas, Texas. AIS, BCBSMS, BCBSA, and Advanced Health Systems, Inc. ("AHS") have settled all disputes arising out of, relating to, or concerning the claims and issues asserted by the parties to the legal proceedings in the lawsuit known as Bond Pharmacy d/b/a Advanced Infusion Solutions v. Removed To Federal Court Counsel at Phelps Dunbar and Sheppard, Mullin, Richter & Hampton on Friday removed a breach-of-contract class action lawsuit against Bond Pharmacy, Advanced Infusion. [21-30534] (DLJ) [Entered: 08/27/2021 12:27 PM]. A subscription to PACER is required. (Winsten, I.) Lists Featuring This Company Texas Health Care Companies (Top 10K) 9,875 Number of Organizations $24.7B Total Funding Amount 1,718 Number of Investors Track P. 57. (citing Twombly, 550 U.S. at 555). Use the links below to access additional information about this case on the US Court's PACER system. A federal district judge in Baltimore, Md., yesterday stayed the brand drug industry's lawsuit challenging the December 2020 340B program administrative dispute resolution final rule. Video/Audio Exhibits on File in District Court? Redaction Request due 7/27/2021. Doesn't sound . Listed below are those cases in which this Featured Case is cited. Descubrir Personas Learning Empleos Unirse ahora . AIS is a specialty pharmacy that provides home infusion therapy, which infuses patients' pain medications into the intrathecal space surrounding their spinal cord through surgically implanted pumps. 2022 Beckoning-cat.com. Lead Counsel? AIS Healthcare is proud to announce that its two state-of-the-art 503A compounding pharmacies (Ridgeland, Mississippi; Dallas, Texas) which produce patient-specific prescriptions for targeted drug delivery (TDD), and its five Advanced Infusion Care locations (Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; Dallas, Texas) have received the prestigious URAC . [21-30534] (SEP) [Entered: 09/15/2021 10:20 AM], APPEARANCE FORM FILED by Attorney Roberta Louise Burns for Appellant Randy Denning in 21-30534. Lead Counsel? Submit your story on our web site for free, for millions to see. Limbert v. Miss. Court: Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, 2:21-cv-10076 Brought to you by the RECAP Initiative and Free Law Project, a non-profit dedicated to creating high quality open legal information. 2010) (citation omitted). Mississippi, Northern Division.https://leagle.com/images/logo.png. According to BCBS and AHS, this was a special pharmacy function and did not warrant payment under the per diem S9328 code. The basis for the action "lies in a promise, which is implied in law, that one will pay to the person entitled thereto [that] which in equity and good conscience is his." Platt, RPh LLC. AIS moves to dismiss BCBS and AHS's counter claims under Rule 12(b)(6). Id. (Entered: 01/28/2021), (#4) ATTORNEY APPEARANCE: Scott R. Knapp appearing on behalf of Blue Cross Blue Shield of Michigan (Knapp, Scott) (Entered: 01/21/2021), (#3) SUMMONS Issued for *Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions* (NAhm) (Entered: 01/12/2021), (#2) STATEMENT of DISCLOSURE of CORPORATE AFFILIATIONS and FINANCIAL INTEREST by Blue Cross Blue Shield of Michigan (Moody, Nolan) (Entered: 01/11/2021), (#1) COMPLAINT filed by Blue Cross Blue Shield of Michigan against Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. advanced infusion solutions lawsuit. Electronic ROA due on 09/30/2021. (Winsten, I.) The plausibility standard does not ask for a probability of unlawful conduct but does require more than a "sheer possibility." The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. (Entered: 01/28/2021), Docket(#5) NOTICE of Appearance by I. W. Winsten on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Plaintiff / Appellant: Randy Denning. 28 U.S.C. February 7, 2022. Id. La. (Entered: 03/04/2021), (#7) ORDER for Extension of Time to Respond to Complaint #1 , ( Response due by 3/4/2021) Signed by District Judge Denise Page Hood. Id. [62] 88-144. VP, Managed Care (Former Employee) - Ridgeland, MS - May 12, 2020 Listed below are the cases that are cited in this Featured Case. may be available from PACER. by | Jul 2, 2022 | orion construction group | how long can a frozen burrito sit out | Jul 2, 2022 | orion construction group | how long can a frozen burrito sit out Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. Jul. In contrast, BCBS and AHS claim they set forth factual descriptions and direct allegations constituting AIS's fraudulent scheme, such that AIS has notice. Advanced Pain Management's clinic at 4448 W. Loomis Road in Greenfield. Located at 7110 Forest Avenue, Infusion Solutions is the first independent infusion center in Central Virginia. Id. 2:23-CV-10279 | 2023-02-02, U.S. District Courts | Contract | See AIS's Memo. We bill your health insurance provider directly for all medication and services, and work directly with the insurer to facilitate your reimbursement. Subscribe to Justia's Free Newsletters featuring summaries of federal and state court opinions. (Knapp, Scott) (Entered: 03/10/2021), Docket(#8) MOTION to Dismiss Plaintiff's Complaint by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Receipt No: AMIEDC-8266539 - Fee: $ 402. Founders Chuck Bell Operating Status Active Company Type For Profit Phone Number 601.988.1700 AIS Healthcare is the provider of targeted drug delivery and infusion care. 2:19-CV-11980 | 2019-07-02, U.S. District Courts | Contract | (Dawson, Rian) (Entered: 04/09/2021), (#18) MOTION to Dismiss Plaintiff's Amended Complaint by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. [21-30534] (SEP) [Entered: 09/15/2021 10:19 AM], APPEARANCE FORM for the court's review. 2:19-CV-02695 | 2019-06-20, U.S. District Courts | Civil Right | Bradley v. Kelley Bros. v. Contractors Inc.,117 So.3d 331, 338 (Miss. Yes. (Entered: 05/12/2021), Docket(#23) NOTICE OF HEARING BY VIDEO CONFERENCE on #18 MOTION to Dismiss Plaintiff's Amended Complaint. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, Attorney at Sheppard Mullin Richter & Hampton, LLP, Attorney at Sheppard, Mullin, Richter & Hampton LLp, Attorney at Sheppard Mullin Richter and Hampton, LLP, Attorney at Sheppard Mullin Richter & Hampton LLP, Exhibit 3 - October 16, 2020 Letter from P. Werner to M. Martinez, Exhibit 2 - October 6, 2020 Letter from M. Martinez to J. Finley, Docket(#25) TRANSCRIPT of Hearing on Defendant's Motion to Dismiss held on 06/23/2021. Advanced Pain . AIS sued BCBS and AHS, asserting breach of contract, breach of implied duty of good faith and fair dealing, unjust enrichment, breach of implied-in-fact contract, and failure to provide benefits under ERISA plans, and seeking declaratory judgment that it is entitled to payment. Denning v. Bond Pharmacy, Inc. (2:21-cv-00774), Louisiana Eastern District Court, Filed: 04/16/2021 - PacerMonitor Mobile Federal and Bankruptcy Court PACER Dockets Fed. Further, "[t]he existence of another adequate remedy does not preclude a declaratory judgment that is otherwise appropriate." Request information NOA filed by Appellant Mr. Randy Denning. No. Finally, one place to get all the court documents we need. Id. Accepting these allegations as true, BCBS and AHS have plausibly stated both elements for breach of contract. Thus, the Court denies AIS's motion on this claim. P. 8(d)(2). 2005) (citation omitted). 2:23-CV-00124 | 2023-01-31, U.S. District Courts | Property | ), Blue Cross Blue Shield of Michigan v. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, (#25) TRANSCRIPT of Hearing on Defendant's Motion to Dismiss held on 06/23/2021. The NPI Number for Advanced Infusion Solutions is 1346742376. BCBS and AHS seek declaratory judgment, asking the Court to declare that BCBS has no contractual obligation to pay the alleged unpaid, mispresented claims. Transcript Order ddl satisfied. (LSau) (Entered: 02/18/2021), Docket(#6) STIPULATION by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions (Winsten, I.) This case was filed in U.S. District Courts, Michigan Eastern District Court. (Entered: 01/28/2021), Docket(#4) ATTORNEY APPEARANCE: Scott R. Knapp appearing on behalf of Blue Cross Blue Shield of Michigan (Knapp, Scott) (Entered: 01/21/2021), Docket(#3) SUMMONS Issued for *Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions* (NAhm) (Entered: 01/12/2021), Docket(#2) STATEMENT of DISCLOSURE of CORPORATE AFFILIATIONS and FINANCIAL INTEREST by Blue Cross Blue Shield of Michigan (Moody, Nolan) (Entered: 01/11/2021), Docket(#1) COMPLAINT filed by Blue Cross Blue Shield of Michigan against Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Escamilla v. Blue Cross Blue Shield of Michigan, d/b/a BCBSM, Wilber v. Compcare Health Services Insurance Corp et al, Mills v. Blue Cross Blue Shield Association et al, Nichols v. Blue Cross Blue Shield of Michigan, Michigan Catastrophic Claims Association v. Steadfast Insurance Company, Bradley v. Blue Cross Blue Shield of Michigan, Display Pack, Inc. v. LEL International, Inc. et al, Romano v. Blue Cross Blue Shield of Michigan. (LSau) (Entered: 04/06/2021), (#10) NOTICE of Appearance by Paul Anthony Werner, III on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. 2008). Advanced Infusion Solutions, (see Bond Pharmacy, Inc. ), Ridgeland, MS - 503A Facility Advanced Nutriceuticals, LLC, Indianapolis, IN - 503A Facility Warning Letter (11/10/2021) 483 Issued. We have the following opinions for this case: This docket was last retrieved on October 25, 2021. Image Trademark. 13. (Dawson, Rian) (Entered: 04/09/2021), Docket(#18) MOTION to Dismiss Plaintiff's Amended Complaint by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. [21-30534] (SEP) [Entered: 09/24/2021 08:54 AM], TRANSCRIPT ORDER received from Appellant Mr. Randy Denning advising transcript unnecessary as it is already filed. BOND PHARMACY v. ADVANCED HEALTH SYSTEMS, INC. United States District Court, S.D. Action: Case OK to Process. [Previously dismissed case: No] [Possible companion case(s): None] (Moody, Nolan) (Entered: 01/11/2021). [21-30534] (DDL) [Entered: 10/25/2021 04:31 PM], CLERK ORDER granting motion to supplement the record on appeal filed by Appellant Mr. Randy Denning [ # 9692325-2 ] [21-30534] (AGL) [Entered: 10/22/2021 08:19 AM], SUPPLEMENTAL ELECTRONIC RECORD ON APPEAL REQUESTED from District Court for 2:21-CV-774. Namely, AIS contends they fail to establish the representation, materiality, and intent elements of the claim and to allege the "who, what, when, where, and how." Date of service: 10/19/2021 via email - Attorney for Appellants: Burns, Camel, Richardson; Attorney for Appellees: Matini, Patron, Spencer-Davis, Werner [21-30534] (Roberta Louise Burns ) [Entered: 10/19/2021 02:16 PM], APPEARANCE FORM for the court's review. United States ex rel. They contend AIS merely delivered the pharmaceutical component to other providers who administered the drug and managed the patient's care. P. 9(b). $24,000 - $37,999 10% of jobs $38,000 - $51,999 12% of jobs $57,000 is the 25th percentile. "To show R. Civ. $52,000 - $65,999 10% of jobs $66,000 - $79,999 13% of jobs The average salary is $93,518 a year $80,000 - $93,999 13% of jobs $94,000 - $107,999 12% of jobs King & Spalding and Bradley Arant Boult Cummings filed a lawsuit Sunday in Illinois Northern District Court on behalf of Bond Pharmacy d/b/a Advanced Infusion Solutions (AIS). (Winsten, I.) Sufficient Mtn/Resp/Reply due on 10/26/2021 for Appellant Randy Denning. Motion Hearing set for 6/23/2021 04:00 PM before District Judge Denise Page Hood |Zoom Webinar Information: https://www.zoomgov.com/j/1616326086?pwd=dTVZRnlseVBTNFRhNVE0SlhQaEozUT09 Passcode: 999999 Or One tap mobile : US: +16692545252,,1616326086# or +16468287666,,1616326086#| (LSau) (Entered: 05/11/2021), (#22) NOTICE of Appearance by Kevin M. Cloutier on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Headquarters 18451 Dallas Pkwy Ste 150, Dallas, Texas, 75287, United States Phone Number (601) 988-1700 Website www.aiscaregroup.com Revenue $23M Industry Pharmaceuticals Healthcare AIS Healthcare's Social Media Is this data correct? Yes. Advanced Infusion Care Our divisions Setting new quality standards in our pharmacies At our state-of-the-art pharmacies, we go beyond state and industry standards to produce patient-specific prescriptions of the highest quality and sterility. [21-30534] (SEP) [Entered: 09/14/2021 03:22 PM], APPEARANCE FORM FILED by Attorney(s) Charles H. Spencer-Davis for party(s) Appellee Bond Pharmacy, Incorporated, in case 21-30534. [21-30534] (Timothy Richardson ) [Entered: 09/14/2021 09:46 AM], APPEARANCE FORM FILED by Attorney Paul Anthony Werner III for Appellee Bond Pharmacy, Incorporated in 21-30534 [21-30534] (CB) [Entered: 09/14/2021 08:29 AM], ATTORNEY TRANSCRIPT ORDER form filed by Appellant Mr. Randy Denningfor the Court to process. Leagle.com reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions. Motion Hearing set for 6/23/2021 04:00 PM before District Judge Denise Page Hood |Zoom Webinar Information: https://www.zoomgov.com/j/1616326086?pwd=dTVZRnlseVBTNFRhNVE0SlhQaEozUT09 Passcode: 999999 Or One tap mobile : US: +16692545252,,1616326086# or +16468287666,,1616326086#| (LSau) (Entered: 05/11/2021), Docket(#22) NOTICE of Appearance by Kevin M. Cloutier on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Text Size:thredup ambassador program how to dress more masculine for a woman. Compl. The Court denies AIS's motion on this claim. United States District Court, S.D. Supplemental Electronic ROA due on 11/08/2021. (Knapp, Scott) (Entered: 03/10/2021), (#8) MOTION to Dismiss Plaintiff's Complaint by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Based on the record as it presently . 25. Public Records Policy. Platt, RPh LLC. No. Balloon Sleeve Big silhouette Over Shirt/ Steury v. Cardinal Health, Inc.,625 F.3d 262, 266 (5th Cir. Id. [21-30534] (SEP) [Entered: 09/29/2021 03:02 PM], BRIEFING NOTICE ISSUED A/Pet's Brief Due on 10/27/2021 for Appellant Randy Denning. 1992) (citation omitted). Advanced Infusion Solutions insights Based on 16 survey responses What people like Ability to learn new things Ability to meet personal goals Areas for improvement Sense of belonging Support from manager Trust in colleagues Interesting niche business with big focus on quality. Nora Apothecary and Alternative Therapies, Inc. AIS now moves to dismiss the counterclaim under Federal Rule of Civil Procedure Rule 12(b)(6). Id. Phone/Fax numbers are the same for each location: Phone: 360-933-4892 Toll Free: 888-960-1873 Fax: 360-933-1197. How Much Do Advanced Infusion Solutions Jobs Pay per Year? Redaction Request due 7/27/2021. [21-30534] (DLJ) [Entered: 09/08/2021 12:40 PM], PRIVATE CIVIL DIVERSITY CASE docketed. Owned by: Advanced Infusion Solutions Acquisition, LLC Serial Number: 87399535. D/B/A ADVANCED INFUSION CARE Court:United States District Court, Eastern District of Louisiana Date published: Jul 30, 2021 CitationsCopy Citation Civil Action 21-774 (E.D. Get billing and insurance guidance At AIS Healthcare, we want to make the billing and reimbursement process as easy as possible for you. "Threadbare recitals of the elements of a cause of action, supported by mere conclusory statements" do not satisfy a plaintiff's pleading burden. Learn more about our pharmacies: AIS Healthcare Targeted Drug Delivery Nursing that exceeds expectations Docket alerts are an advanced feature of CourtListener. The NPI number of this provider is 1336243393 and was assigned on September 2006. The Counterclaim alleges that each time AIS improperly billed using the S9328 code it made a representation that it had performed those services when it had not. Blog Lawyers for Pharmaceutical Research and Manufacturers of America and U.S. Health and Human Services Secretary Xavier Becerra on Friday jointly asked U.S . We have designed private, spacious, comfortable, and relaxing suites which include: Heated massage chairs. The elements of fraud and intentional misrepresentation are identical, and therefore Rule 9(b)'s heightened pleading standard applies to the latter claim. Get free access to the complete judgment in Bond Pharmacy v. Advanced Health Sys. Repair Your Reputation The Right Way Corporate Advocacy Program "A breach is material where there is `a failure to perform a substantial part of the contract or one or more of its essential terms or conditions, or if there is such a breach as substantially defeats [the purpose of the contract].'" Last updated on September 30th, 2020 at 11:43 am The closure of Advanced Pain Management ambulatory surgical centers and. Plaintiff requests summons issued. Published: June 7, 2022 Categorized as: imprisonment 5e dndbeyond . The Court therefore denies AIS's motion on this claim. Fed. Find a Advanced Infusion Solutions in your State Mississippi Popular Prescriptions at Advanced Infusion Solutions Losartan Potassium Tablet, 25 Mg, 30.000 Tablets $ 8.79 Tablet,, 12.000 Tablets , 20 mg, 248.73 Tablet, 400 Mg, 20.000 Tablets $ 8.14 Tablet Dr, 20 Mg, 30.000 Tablet Enteric Coateds $ 9.36 GENERIC Other Popular Pharmacies Near Me The mailing address for Advanced Infusion Solutions is 623 Highland Colony Parkway, Suite 100, Ridgeland, Mississippi - 39157-6077 (mailing address contact number - 877-443-4006). Appeal from the United States District Court . Sufficient Mtn/Resp/Rpl deadline satisfied. 2:21-CV-12966 | 2021-12-20. 2010). 2008) (quoting Hughes v. The Tobacco Inst., Inc.,278 F.3d 417, 420 (5th Cir. Advanced Infusion Care Clinton 132 Fairmont Street, Suite B Clinton, MS 39056 P: 601.988.1710 I 888.339.2144 F: 229.242.9914 I 844.259.0209 URAC accredited for Specialty Pharmacy Advanced Infusion Care Valdosta 212 Northside Drive Valdosta, GA 31602 P: 229.242.3060 | 800.482.8466 F: 229.242.9914 URAC accredited for Specialty Pharmacy Industry: Health maintenance organization , Drug stores and proprietary stores Printer Friendly View Address: 623 Highland Colony Pkwy Ste 100 Ridgeland, MS, 39157-6077 United States See other locations Phone: Website: www.aiscaregroup.com Employees (this site): Actual ESG industry average: What is D&B's ESG Ranking? 15. Healthy snacks. Bond Pharmacy, Inc. dba Advanced Infusion Solutions United States Recipient: United States DUANE MORRIS LLP 190 SOUTH LASALLE STREET, SUITE 3700 CHICAGO, IL 60603-3433 PHONE: +1 312 499 6700. Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. Because the Counterclaim provides enough particularity to provide AIS with notice, the Court denies AIS's motion on this claim. The Court has the authority to "declare the rights and other legal relations of any interested party seeking such declaration" pursuant to the Declaratory Judgment Act. . [email protected] advanced infusion solutions lawsuit. Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. 3:11 . This Court dismissed the ERISA claims. These allegations are sufficient to plausibly state a claim for breach of good faith and fair dealing. If no request is filed, the transcript may be made remotely electronically available to the public without redaction after 90 days. Our inspiration came from the infusion experiences of our close family: Annette's brother and Lucien's father. Physical address: Carr. [47] 32. County of 1st Plaintiff: Wayne - County Where Action Arose: Wayne - County of 1st Defendant: Out of State. Human Drug Compounding, Recalls, Market Withdrawals and Safety Alerts, Compounding Quality Center of Excellence On-demand Training, Compounding Oversight and Compliance Actions, Compounding: Inspections, Recalls, and other Actions, Consumer and Health Care Professional Information, Guidance, Compliance, & Regulatory Information, 2014 - 2015 Compounding: Inspections, Recalls, and other Actions, Referral Letter to the California State Board of Pharmacy Issued 07/06/2020, Referral Letter to the Florida State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Virginia State Board of Pharmacy dated 01/29/2020, Referral Letter to the Missouri Board of Pharmacy dated 06/16/2022, Referral Letter to the Nevada State Board of Pharmacy dated 07/13/2022, Referral Letter to the Virginia State Board of Pharmacy Issued 06/08/2017, Referral Letter to the New York State Board of Pharmacy Issued 05/08/2017, Referral Letter to the Delaware State Board of Pharmacy Issued 04/28/2017, Referral Letter to Florida State Board of Pharmacy Issued 10/09/2015, Referral Letter to the New York State Board of Pharmacy Issued 03/22/2017, Referral Letter to Florida Board of Pharmacy Issued 02/21/2014, Referral Letter to State of New Hampshire Board of Pharmacy Issued 06/07/2016, Referral Letter to the Kansas State Board of Pharmacy Issued 03/06/2019, Referral Letter to the North Carolina State Board of Pharmacy Issued 08/19/2019, Referral Letter to the Arizona State Board of Pharmacy Issued 04/09/2020, Referral to the Rhode Island State Board of Pharmacy Issued 07/25/2017, Referral Letter to the California State Board of Pharmacy Issued 08/31/2017, Referral to the New York State Board of Pharmacy Issued 11/16/2017, Referral Letter to the Mississippi Board of Pharmacy Issued 08/02/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 10/29/2019, Referral Letter to the Ohio State Board of Pharmacy Issued 05/01/2019, Referral Letter to the Florida Board of Pharmacy Issued on 01/31/17, Referral Letter to the Georgia State Board of Pharmacy Issued 11/18/2019, Referral to the Connecticut State Board of Pharmacy Issued 07/12/2017, Referral Letter to the Louisiana Board of Pharmacy Issued 11/03/2022, Referral Letter to the Michigan Board of Pharmacy Issued 03/22/2017, Referral Letter to the Ohio State Board of Pharmacy Issued 08/09/17, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 01/17/17, Referral Letter to the California State Board of Pharmacy Issued 07/20/2020, FDA Alerts Health Care Professionals and Patients not to Use Sterile Drug Products from Chen Shwezin Inc., dba Park Compounding Pharmacy, Referral Letter to the Michigan Board of Pharmacy Issued 09/09/16, Referral Letter to the Ohio Board of Pharmacy Issued 05/30/2014, Referral Letter to the Mississippi State Board of Pharmacy Issued 11/05/2019 Shutdown Letter, Referral Letter to the Mississippi Board of Pharmacy Issued 06/27/2019, Referral Letter to the Georgia State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Indiana State Board of Pharmacy Issued 10/02/2019, Referral Letter to the Arkansas State Board of Pharmacy Issued 10/28/2020, Referral Letter to the California State Board of Pharmacy Issued 12/14/2015, Leader of $17 Million Health Insurance Fraud Scheme Ordered to Prison, Referral Letter to the Texas State Board of Pharmacy Issued 05/18/2020, FDA Requested Recall Letter Issued 09/09/2014, FDA Requested Recall Letter Issued 07/26/2013, Referral Letter to New Jersey State Board of Pharmacy Issued 02/21/2014, Referral Letter to the Georgia State Board of Pharmacy Issued 05/19/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/29/2019, FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding, Referral Letter to Missouri Board of Pharmacy Issued 02/26/2014, Referral Letter to the Alaska State Board of Pharmacy dated 02/18/2020, Referral Letter to the Alaska State Board of Pharmacy dated 02/06/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/08/2017, FDAs Investigation into Guardians Compounded Triamcinolone-Moxifloxacin Drug Product, FDA Alerts Health Care Professionals of Adverse Events Associated with Guardians Compounded Triamcinolone and Moxifloxacin Product for Intravitreal Injection, Corrected (No Redactions) 483 Issued 10/21/2016, Referral Letter to the Texas State Board of Pharmacy Issued 03/24/2021, Referral to the California State Board of Pharmacy Issued 09/26/2017, Referral Letter to the Michigan State Department of Licensing and Regulatory Affairs (LARA) Issued 05/21/2015, Referral Letter to the Florida State Board of Pharmacy Issued 01/23/2017, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 03/27/2014, Referral Letter to the Texas State Board of Pharmacy Issued 05/05/2016, Referral Letter to the Maryland State Board of Pharmacy Issued 08/23/2019, A Case of Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation, FDA Investigates Two Serious Adverse Events Associated with ImprimisRxs Compounded Curcumin Emulsion Product for Injection, Investigation Memo and Attachments, 08/16/2011, Referral Letter to the Minnesota State Board of Pharmacy Issued 07/01/2019, Referral to the South Carolina State Board of Pharmacy Issued 09/13/2017, Referral Letter to the Ohio Board of Pharmacy Issued 03/28/2019, Referral Letter to the ColoradoBoard of Pharmacy Issued 12/23/2020, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 10/03/2019, Referral Letter to the New Mexico State Board of Pharmacy Issued 08/22/2017, Maxor National Pharmacy Services Corporation, Referral Letter to the Texas Board of Pharmacy Issued 03/18/2014, Alexandria Medical Arts Pharmacy & Compounding Laboratory, Referral Letter to the Florida Board of Pharmacy Issued 04/21/2017, FDA announces Glades Drugs nationwide voluntary recall of Compounded Multivitamins containing High Amounts of Vitamin D3 (Cholecalciferol), Referral Letter to the California State Board of Pharmacy Issued 12/06/2019, Referral Letter to the Missouri State Board of Pharmacy Issued 01/10/2017, Referral Letter to the Missouri State Board of Pharmacy Issued 03/10/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 08/11/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 09/11/2019, Referral Letter to the New York State Board of Pharmacy Issued 11/15/2019, Referral Letter to the California State Board of Pharmacy Issued 11/22/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 07/11/2019, Referral Letter to Oklahoma State Board of Pharmacy Issued 02/25/2014, Referral Letter to the New York State Board of Pharmacy Issued 06/06/2019, Referral Letter to the Massachusetts Department of Public Health Issued 10/14/2015, Referral to the New York State Education Department, Office of the Professions, Pharmacy Issued 07/07/2017, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/10/2019, Referral Letter to the Oklahoma State Board of Pharmacy Issued 10/2/2020, Referral Letter to the Missouri Board of Pharmacy Issued 02/18/2015, FDA Requested Recall Letter Issued 05/03/2016, Referral Letter to the South Carolina State Board of Pharmacy Issued 05/21/2015, Referral to the Texas State Board of Pharmacy Issued 07/28/2017, State Referral Letter to the Nevada State Board of Pharmacy issued 12/06/2017, Referral Letter to Massachusetts Board of Registration in Pharmacy Issued 01/20/2016, Barclay Luke & Pillai Specialty Pharmacy PLLC, Referral Letter to the Arizona State Board of Pharmacy Issued 05/23/2017, Referral Letter to the Michigan State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Tennessee Board of Pharmacy Issued 04/05/2017, Referral Letter to the Wisconsin State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 05/09/2016, Unlicensed Pharmacy Technician Sentenced for Working at New England Compounding Center, Owner and Four Former Employees of New England Compounding Center Convicted Following Trial, Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center, Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud, Multistate outbreak of fungal meningitis and other infections, Referral to the Massachusetts State Board of Registration in Pharmacy Issued 09/26/2017, Referral Letter to New Hampshire State Board of Pharmacy Issued 04/29/2015, Referral Letter to the Kentucky State Board of Pharmacy Issued 03/04/2020, Referral to the Kansas State Board of Pharmacy Issued 06/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 07/01/2020, Referral Letter to the Illinois State Board of Pharmacy Issued 10/31/2019, Referral Letter to the California State Board of Pharmacy Issued 07/08/2020, Referral Letter to Florida State Board of Pharmacy Issued 03/10/2021, Amended 483 and Cover Letter Issued 04/09/2013 and 483 Issued 03/29/2013, Referral Letter to the Tennessee State Board of Pharmacy Issued 09/13/2019, Referral Letter to the Florida State Board of Pharmacy Issued 04/22/2019, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 05/05/2017, Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients, Referral Letter to the Texas State Board of Pharmacy Issued 03/12/2019, Referral Letter to the Kansas State Board of Pharmacy Issued 03/29/2017, Pharmacy Creations Issues Voluntary Recall of Four Product Lots With Limited Distribution in Florida, New Jersey, New York, and Puerto Rico Due to Potential Non-Sterility (09/04/2014), Referral Letter to the Indiana State Board of Pharmacy Issued 03/06/2017, Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Drugs, Referral Letter to the New Jersey State Board of Pharmacy Issued 07/29/2019, Referral to the Oklahoma State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Georgia State Board of Pharmacy Issued 08/14/2020, Referral Letter to New York State Board of Pharmacy Issued 11/07/2016, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/11/2017, Referral Letter to Michigan Board of Pharmacy Issued 02/25/2014, Referral Letter to the California State Board of Pharmacy Issued 04/05/2017, Referral Letter to the Colorado State Board of Pharmacy Issued 04/14/2020, Referral Letter to the FloridaBoard of Pharmacy Issued 07/27/2022, Referral Letter to the Ohio State Board of Pharmacy Issued 09/12/2019, Referral to the New York State Board of Pharmacy Issued 06/15/2017.
Does Joe Spano Have Cancer,
Spandau Ballet Member Dies,
Articles A
